TDSPharm Co

TDSPharm Co EBITDA per Share

The EBITDA per Share of TDSPharm Co (464280.KQ) as of Oct 24, 2026 is 711.96 KRW. In the previous year, EBITDA per Share was 746.86 KRW — a change of -4.67% (lower).

EBITDA per Share

711.96KRW

YoY

-4.67%

Last updated:

EBITDA per Share of TDSPharm Co is 2025 711.96 KRW. EBITDA per Share of TDSPharm Co was 2024 746.86 KRW. It decreases by -4.67% lower compared to the previous year.

The TDSPharm Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
471.98 KRW
Jan 1, 2022
836.50 KRW
Jan 1, 2023
1,082.64 KRW
Jan 1, 2024
746.86 KRW
Jan 1, 2025
711.96 KRW
The TDSPharm Co EBITDA per Share history
YEAREBITDA per ShareYoY
711.96KRW-4.67%
746.86KRW-31.01%
1,082.64KRW+29.42%
836.50KRW+77.23%
471.98KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

TDSPharm Co Stock analysis

What does TDSPharm Co do? TDSPharm Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TDSPharm Co stock

EBITDA per Share of TDSPharm Co is 711.96 KRW in 2025.

EBITDA per Share of TDSPharm Co changed from 746.86 KRW to 711.96 KRW, representing a -4.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share TDSPharm Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — TDSPharm Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — TDSPharm Co